Pos-314 polypharmacy and potentially inappropriate medication use in patients with ckd managed in canadian primary care

M. TINWALA, D. Zaidi,F. Ye,S. Muneer,A. Ghimire,M. Khan,N. Sultana, I. Okpechi G., P. Ronksley E.,N. Drummond,D. Mangin, A. Bello K.

Kidney International Reports（2022）

引用 0|浏览7

暂无评分

摘要

Polypharmacy and the use of potentially inappropriate medications (PIMs) are an increasingly serious public health challenge attributable to aging populations and multimorbidity. This study assessed the prevalence of polypharmacy and use of PIMs in chronic kidney disease (CKD).

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要